+ Vet Pharmacovigilance : Experiences in Horses EMA London FVE - - PowerPoint PPT Presentation

vet pharmacovigilance experiences in horses ema london
SMART_READER_LITE
LIVE PREVIEW

+ Vet Pharmacovigilance : Experiences in Horses EMA London FVE - - PowerPoint PPT Presentation

+ Vet Pharmacovigilance : Experiences in Horses EMA London FVE Nov 2016 + The Horse : center of a unique world + Working animal Transportation Field work Money maker Equine industry High level sport Gambling The


slide-1
SLIDE 1

+

Vet Pharmacovigilance : Experiences in Horses

EMA London FVE Nov 2016

slide-2
SLIDE 2

+ The Horse : center of a unique world

slide-3
SLIDE 3

+

The Horse : a unique animal

 Working animal  Transportation  Field work  Money maker  Equine industry  High level sport  Gambling  Leisure  God  Food producer MANY DESTINATIONS

slide-4
SLIDE 4

+

The Horse : a unique animal

 Food animal  Meat producer  Breeders, slaughters, butchers,

consumers…, Vets

 Specialized but Opened industry  Origin traceability  Minor species FOOD ANIMAL

slide-5
SLIDE 5

+

The Horse : a unique animal

 Drug availability  Market authorizations  European / International market  Medical knowledge  Vet Responsability  Medical challenge  Vet competition  Horses value  Legislation  LMR  Cascade  Antibiotics  EL  Exclusion  ‘Science’  Clients  Dreams MINOR SPECIES VET CHALLENGES

slide-6
SLIDE 6

+

Equine pharmacovigilance : FVE, Europe

 3545 vet answers  668 France  Horses  5%  Side effects  Lack of efficacy

2015 2015

slide-7
SLIDE 7

+

Equine pharmacovigilance : ANMV, France

 3190 declarations  side effects  90% by vets  83% small animals  Horses  <3%  3857 declarations – 98/horses  SA 81%>BV 9%>Horses 2,5%  Species #2 (#1=cats)  1 declaration /8000 horses

2013 2015

0.1 0.2 0.3 0.4 0.5

ANMV 2015 declarations

slide-8
SLIDE 8

+

Equine pharmacovigilance : ANMV, France

 98 declarations  side effects  44 important  22 deaths  657 declarations  1051 horses  349 imp  209 deaths

2015 10 years : 2005 - 2015

10 20 30 40 50 60 70

Equine side effects reported %

50 100 150 200 250

Imp equine reports/category

Imp Non imp

slide-9
SLIDE 9

+

Equine pharmacovigilance : ANMV, France

 133 drugs  5 ‘top categories’  214 drugs  5 ‘top categories’

2015 10 years : 2005 - 2015

Vaccines 33% Anesth /NS 31% AI 9% AB 8% Dewormers 8% Others 11%

Drug category 2015

Vaccines 27% Anesth /NS 18% AI 10% AB 15% Dewormers 16% Others 14%

Drug category 2005-2015

slide-10
SLIDE 10

+

Equine pharmacovigilance : ANMV, France

 133 drugs  5 ‘top categories’  214 drugs  5 ‘top categories’

2015 10 years : 2005 - 2015

10 20 30 40 50 60 Vaccines Anesth /NS AI AB Dewormers Others 2015 2005-2015

slide-11
SLIDE 11

+

Equine pharmacovigilance : AVEF, France

 73 vets / 24h  69% = pure equine practice  Time in practice  From 2 to >30 years

Nov 2016 Nov 2016

69% 8% 10% 8% 5%

Equine practice %

100% 75-90% 50-75% 25-50% <20% 2--5 6--10 11--15 15--20 21--25 26--30 >30 10 20 11 10 8 6 8

Years of experience

slide-12
SLIDE 12

+

Equine pharmacovigilance : AVEF, France

 What for ?  Side effects 70%  Mortality 31%  Lack of efficacy 23%  Where to declare ?  Industry 43%  ANMV 28%

Nov 2016 Nov 2016

Mortality 31% Lack of efficacy 23% Availability 4% Side effects 36% Price report 1% Sales practices 5%

Pharmacovigilance

10 20 30 40 50 Industry Centrale DGAL ANMV AVEF SNGTV CNITV Ordre

Where to declare

slide-13
SLIDE 13

+

Equine pharmacovigilance : AVEF, France

 Experience of drug problem  Yes = 64%  Nb of declarations  Yes = 57%

Nov 2016 Nov 2016

YES 89% NO 11%

Drug problem

no, never 41% yes, 1 time 28% yes, 2 - 5 times 27% yes, >5 times 4%

Nb of declarations

slide-14
SLIDE 14

+

Equine pharmacovigilance : AVEF, France

 Drugs categories  AB = 35%  Vaccines = 19%  AI = 14%  Anesthetics = 9%

Nov 2016 Nov 2016

5 10 15 20 25 30 35

Drug category

slide-15
SLIDE 15

+

Equine pharmacovigilance : AVEF, France

 60 molecules reported  Top 6 drugs  Penicillin

10/60

 Critical AB

7/60

 Biphosphonates

7/60

 Anesthetics

6/60

 Herpes vaccines

5/60

 Imidocarbe

4/60 Nov 2016 Nov 2016

Peni 26% Critical AB 18% Biphosphonates 18% Anesth 15% Herpes vaccine 13% Imidocarbe 10%

Top 6 drugs

slide-16
SLIDE 16

+

Equine pharmacovigilance : AVEF, France

 Comments by vets  Lack of answer back  Too much time to report

Nov 2016 Nov 2016

YES 41% NO 59%

Answer back

slide-17
SLIDE 17

+

Pharmacovigilance in Horses

In Practice NOW

 More reports by vets

 Help by tecnical associations?  Scientific papers  Save + more drugs / horses

FUTURE

 Reports by vets

 Time to report  Increasing interest  Responsability  Out of label drug uses …

slide-18
SLIDE 18

+

Equine Pharmacovigilance

 Horse’s welfare  Vet position  Public health

slide-19
SLIDE 19

+

THANK YOU

Treat better !

Claire Scicluna